Fortis Advisors’s Labcorp LH Stock Holding History

Fortis Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-125	Closed	-$14K	–	251
2020 Q1	$14K	Buy	+125	New	+$18K	0.01%	242

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fortis Advisors's LH Position: Q2 2020 in Review

Fortis Advisors sold out of Labcorp (LH) in Q2 2020, closing a stake of 125 shares — an estimated $14K sold.

Fortis Advisors first reported a position in LH in Q1 2020 and held it in 1 quarter. The position peaked at $14K in Q1 2020. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

Fortis Advisors reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
Fortis Advisors sold 125 Labcorp shares in Q2 2020, an estimated $14K.
Fortis Advisors first reported a position in Labcorp in Q1 2020 and held it in 1 quarter.
Fortis Advisors's Labcorp position peaked at $14K in Q1 2020.
798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.